We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

2 hedge funds and large institutions have $442 invested in Avadel Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 202 closing their positions.

New
Increased
Maintained
Reduced
Closed

75.53% less ownership

Funds ownership: 75.53% → 0% (-76%)

99% less funds holding

Funds holding: 207 → 2 (-205)

100% less funds holding in top 10

Funds holding in top 10: 8 → 0 (-8)

100% less capital invested

Capital invested by funds: $1.6B → $442 (-$1.6B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 202

Holders
2
Holders Change
-205
Holders Change %
-99.03%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
202
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$152M
2
GJL
Gendell Jeffrey L
-$103M
3
WAM
Weiss Asset Management
Massachusetts
-$97.3M
4
TAL
TIG Advisors LLC
New York
-$83.2M
5
Tudor Investment Corp
Tudor Investment Corp
Connecticut
-$64.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
AA
76
AQR Arbitrage
Connecticut
– -$2.38M -110,396 Closed
RhumbLine Advisers
77
RhumbLine Advisers
Massachusetts
– -$2.32M -107,493 Closed
State of Wisconsin Investment Board
78
State of Wisconsin Investment Board
Wisconsin
– -$2.31M -107,104 Closed
PAMP
79
Polar Asset Management Partners
Ontario, Canada
– -$2.27M -105,399 Closed
Federated Hermes
80
Federated Hermes
Pennsylvania
– -$2.19M -101,711 Closed
AllianceBernstein
81
AllianceBernstein
Tennessee
– -$2.12M -98,438 Closed
Arrowstreet Capital
82
Arrowstreet Capital
Massachusetts
– -$2.02M -93,528 Closed
Group One Trading
83
Group One Trading
Illinois
– -$2M -93,028 Closed
Millennium Management
84
Millennium Management
New York
– -$1.81M -84,085 Closed
IAMOG
85
Investors Asset Management of Georgia
Georgia
– -$1.79M -83,275 Closed
California State Teachers Retirement System (CalSTRS)
86
California State Teachers Retirement System (CalSTRS)
California
– -$1.79M -82,996 Closed
QT
87
Quantbot Technologies
New York
– -$1.72M -79,909 Closed
RC
88
Rangeley Capital
Connecticut
– -$1.64M -75,953 Closed
Los Angeles Capital Management
89
Los Angeles Capital Management
California
– -$1.42M -75,331 Closed
Two Sigma Investments
90
Two Sigma Investments
New York
– -$1.54M -71,336 Closed
Invesco
91
Invesco
Georgia
– -$1.47M -68,159 Closed
Susquehanna International Group
92
Susquehanna International Group
Pennsylvania
– -$1.33M -61,690 Closed
CL
93
CSS LLC
Illinois
– -$1.27M -59,037 Closed
Franklin Resources
94
Franklin Resources
California
– -$1.27M -58,821 Closed
OQS
95
Occudo Quantitative Strategies
Florida
– -$1.16M -53,730 Closed
T. Rowe Price Associates
96
T. Rowe Price Associates
Maryland
– -$1.12M -51,970 Closed
MIM
97
MetLife Investment Management
New Jersey
– -$1.09M -50,708 Closed
SG Americas Securities
98
SG Americas Securities
New York
– -$1.08M -50,366 Closed
Two Sigma Advisers
99
Two Sigma Advisers
New York
– -$989K -45,900 Closed
TAM
100
TFG Asset Management
Cayman Islands
– -$943K -43,763 Closed
2 3
4
5 6

AVDL Hedge Fund Activity: Q1 2026 in Review

2 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q1 2026, worth a combined $442 — down 100% from $1.6B a quarter earlier.

Sellers outnumbered buyers: 202 funds closed out of AVDL and 0 opened new positions — a net loss of 202 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $152M sold.

  • 2 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q1 2026, down from 207 in Q4 2025.
  • Funds reported $442 of Avadel Pharmaceuticals stock for Q1 2026, down 100% quarter-over-quarter.
  • 0 funds opened new Avadel Pharmaceuticals positions in Q1 2026 and 202 closed out, a net change of -202 holders.
  • The largest Avadel Pharmaceuticals seller in Q1 2026 was BlackRock, an estimated $152M sold.

Based on aggregated 13F filings for Q1 2026.